# TAZAROTENE
> **ANDA213644** · Abbreviated New Drug Application (Generic) · Sponsor: SOLARIS PHARMA CORP · Approved 2023-03-20
## Drug
- **FDA Application Number:** ANDA213644
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TAZAROTENE
- **Generic name:** TAZAROTENE
- **Active ingredients:** TAZAROTENE
- **Dosage form:** GEL
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** SOLARIS PHARMA CORP
- **Manufacturer:** Solaris Pharma Corporation
- **First approval:** 2023-03-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213644)
---
*MORVS · CC0 1.0*